Hiroe Ohyama, D.D.S., D.M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Dental | 11 | 2023 | 160 | 4.770 |
Why?
|
| Dentistry, Operative | 7 | 2022 | 38 | 4.580 |
Why?
|
| Education, Dental | 9 | 2023 | 215 | 2.930 |
Why?
|
| Self-Assessment | 5 | 2021 | 390 | 2.560 |
Why?
|
| Students | 4 | 2022 | 1654 | 1.310 |
Why?
|
| Education, Distance | 2 | 2023 | 251 | 1.280 |
Why?
|
| Licensure, Dental | 1 | 2022 | 18 | 0.840 |
Why?
|
| Educational Measurement | 7 | 2022 | 1210 | 0.830 |
Why?
|
| Clinical Competence | 8 | 2022 | 4687 | 0.650 |
Why?
|
| Immediate Dental Implant Loading | 1 | 2019 | 67 | 0.620 |
Why?
|
| Faculty, Dental | 3 | 2021 | 60 | 0.540 |
Why?
|
| Dental Caries | 3 | 2022 | 415 | 0.430 |
Why?
|
| Students, Medical | 2 | 2022 | 1862 | 0.420 |
Why?
|
| Dental Implants | 1 | 2019 | 749 | 0.380 |
Why?
|
| Educational Technology | 2 | 2022 | 60 | 0.360 |
Why?
|
| Mouth Rehabilitation | 1 | 2007 | 11 | 0.300 |
Why?
|
| Periodontitis | 7 | 2009 | 553 | 0.280 |
Why?
|
| Aggressive Periodontitis | 6 | 2009 | 59 | 0.280 |
Why?
|
| Smiling | 1 | 2007 | 72 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 3920 | 0.270 |
Why?
|
| Esthetics, Dental | 1 | 2007 | 250 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.240 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.240 |
Why?
|
| Mouth Neoplasms | 4 | 2003 | 601 | 0.230 |
Why?
|
| Porphyromonas gingivalis | 5 | 2001 | 169 | 0.230 |
Why?
|
| Tooth Demineralization | 1 | 2022 | 4 | 0.220 |
Why?
|
| Aptitude Tests | 1 | 2022 | 21 | 0.220 |
Why?
|
| Radiography, Bitewing | 2 | 2020 | 36 | 0.210 |
Why?
|
| HLA-DQ Antigens | 5 | 2009 | 210 | 0.210 |
Why?
|
| Micromanipulation | 1 | 2002 | 53 | 0.210 |
Why?
|
| Dissection | 2 | 2020 | 295 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 4 | 2004 | 113 | 0.200 |
Why?
|
| Japan | 3 | 2021 | 1360 | 0.200 |
Why?
|
| Chitosan | 1 | 2022 | 141 | 0.200 |
Why?
|
| Licensure | 1 | 2022 | 124 | 0.190 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2001 | 404 | 0.180 |
Why?
|
| Neck Muscles | 1 | 2020 | 104 | 0.180 |
Why?
|
| Hypoglossal Nerve | 1 | 2020 | 95 | 0.180 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2021 | 230 | 0.170 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 361 | 0.170 |
Why?
|
| Dental Restoration Failure | 1 | 2019 | 152 | 0.160 |
Why?
|
| Humans | 48 | 2023 | 744343 | 0.160 |
Why?
|
| Dental Amalgam | 1 | 2018 | 67 | 0.160 |
Why?
|
| Composite Resins | 1 | 2018 | 74 | 0.160 |
Why?
|
| Feedback | 1 | 2022 | 795 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 2018 | 142 | 0.150 |
Why?
|
| Curriculum | 2 | 2021 | 3605 | 0.150 |
Why?
|
| Polyurethanes | 1 | 2018 | 107 | 0.150 |
Why?
|
| Dental Prosthesis, Implant-Supported | 1 | 2019 | 215 | 0.150 |
Why?
|
| Dental Prosthesis Design | 1 | 2019 | 259 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2005 | 2849 | 0.150 |
Why?
|
| Schools, Dental | 1 | 2018 | 122 | 0.150 |
Why?
|
| Electroporation | 1 | 1998 | 251 | 0.140 |
Why?
|
| Eosinophils | 2 | 1998 | 955 | 0.140 |
Why?
|
| Reading | 1 | 2020 | 558 | 0.140 |
Why?
|
| Gingiva | 2 | 2009 | 388 | 0.130 |
Why?
|
| Antigens, Bacterial | 2 | 1998 | 1171 | 0.130 |
Why?
|
| Genes, MHC Class II | 1 | 1996 | 457 | 0.130 |
Why?
|
| Achievement | 1 | 2017 | 291 | 0.130 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2019 | 502 | 0.130 |
Why?
|
| Transfection | 4 | 2005 | 5892 | 0.110 |
Why?
|
| RNA, Complementary | 2 | 2002 | 45 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2009 | 1475 | 0.100 |
Why?
|
| Chronic Periodontitis | 2 | 2009 | 101 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2003 | 9438 | 0.090 |
Why?
|
| RNA, Neoplasm | 3 | 2002 | 769 | 0.090 |
Why?
|
| HLA-DR Antigens | 5 | 2009 | 645 | 0.080 |
Why?
|
| Learning | 1 | 2018 | 1713 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2009 | 433 | 0.080 |
Why?
|
| Transforming Growth Factor alpha | 2 | 1998 | 135 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2007 | 134 | 0.080 |
Why?
|
| Crown Lengthening | 1 | 2007 | 5 | 0.080 |
Why?
|
| Tooth Attrition | 1 | 2007 | 7 | 0.080 |
Why?
|
| Occlusal Adjustment | 1 | 2007 | 8 | 0.080 |
Why?
|
| Dental Restoration Wear | 1 | 2007 | 7 | 0.080 |
Why?
|
| Tooth Discoloration | 1 | 2007 | 16 | 0.080 |
Why?
|
| Tooth Fractures | 1 | 2007 | 28 | 0.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2007 | 182 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 4751 | 0.070 |
Why?
|
| Lasers | 2 | 2002 | 952 | 0.070 |
Why?
|
| Dental Restoration, Permanent | 1 | 2007 | 127 | 0.070 |
Why?
|
| Crowns | 1 | 2007 | 152 | 0.070 |
Why?
|
| Retreatment | 1 | 2007 | 610 | 0.060 |
Why?
|
| Amino Acid Sequence | 8 | 2004 | 13815 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.060 |
Why?
|
| DNA Polymerase I | 2 | 2000 | 38 | 0.060 |
Why?
|
| HLA Antigens | 2 | 1999 | 1381 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2009 | 4161 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2001 | 671 | 0.050 |
Why?
|
| DNA Primase | 2 | 2000 | 109 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2001 | 10180 | 0.050 |
Why?
|
| Dental Enamel | 1 | 2022 | 64 | 0.050 |
Why?
|
| Caseins | 1 | 2022 | 104 | 0.050 |
Why?
|
| Molecular Sequence Data | 7 | 2004 | 18111 | 0.050 |
Why?
|
| Odontogenic Tumors | 1 | 2002 | 45 | 0.050 |
Why?
|
| Mandibular Neoplasms | 1 | 2002 | 129 | 0.050 |
Why?
|
| Gels | 1 | 2022 | 427 | 0.050 |
Why?
|
| Epitope Mapping | 2 | 2001 | 311 | 0.050 |
Why?
|
| Tic Disorders | 1 | 1981 | 127 | 0.050 |
Why?
|
| Dentin | 1 | 2020 | 73 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2001 | 87 | 0.050 |
Why?
|
| Mandibular Nerve | 1 | 2020 | 58 | 0.050 |
Why?
|
| Basilar Artery | 1 | 1981 | 200 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 1981 | 192 | 0.050 |
Why?
|
| Cysteine | 1 | 2005 | 874 | 0.050 |
Why?
|
| Biotinylation | 1 | 2000 | 179 | 0.050 |
Why?
|
| Trigeminal Neuralgia | 1 | 1981 | 113 | 0.050 |
Why?
|
| Interleukin-6 | 4 | 2009 | 3200 | 0.050 |
Why?
|
| Proteins | 3 | 2000 | 6103 | 0.050 |
Why?
|
| Nerve Compression Syndromes | 1 | 1981 | 160 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 749 | 0.040 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 1999 | 4 | 0.040 |
Why?
|
| Lymphocyte Activation | 3 | 1999 | 5524 | 0.040 |
Why?
|
| Male | 14 | 2021 | 350118 | 0.040 |
Why?
|
| Endodeoxyribonucleases | 1 | 2000 | 165 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 385 | 0.040 |
Why?
|
| Apoptosis | 3 | 2000 | 9727 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1375 | 0.040 |
Why?
|
| Leukemia, Eosinophilic, Acute | 1 | 1998 | 5 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2001 | 1147 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2635 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1996 | 768 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2000 | 371 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2004 | 1097 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1263 | 0.040 |
Why?
|
| Peptide Library | 1 | 1999 | 349 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1640 | 0.040 |
Why?
|
| Chemokine CCL5 | 2 | 2009 | 209 | 0.040 |
Why?
|
| Female | 14 | 2021 | 380194 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1998 | 168 | 0.040 |
Why?
|
| Periodontal Ligament | 1 | 1997 | 118 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 2126 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 3922 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4456 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2009 | 3588 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2001 | 191 | 0.030 |
Why?
|
| Cell Line | 5 | 2005 | 15997 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2002 | 4034 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3479 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2009 | 617 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2005 | 2969 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1267 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2007 | 2531 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 1999 | 449 | 0.030 |
Why?
|
| Cytokines | 2 | 2009 | 7322 | 0.030 |
Why?
|
| Mouth Mucosa | 3 | 2003 | 434 | 0.030 |
Why?
|
| Acyclovir | 1 | 1995 | 272 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14722 | 0.030 |
Why?
|
| ras Proteins | 1 | 1999 | 1060 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2005 | 3772 | 0.030 |
Why?
|
| Genotype | 4 | 2009 | 12951 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 1995 | 144 | 0.030 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6314 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2000 | 1900 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2009 | 17446 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 1998 | 1284 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63114 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2593 | 0.030 |
Why?
|
| Protein Binding | 3 | 2004 | 9386 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1995 | 470 | 0.030 |
Why?
|
| Age of Onset | 1 | 1998 | 3271 | 0.030 |
Why?
|
| Portal System | 1 | 1990 | 52 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1999 | 2617 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
| DNA, Complementary | 3 | 2001 | 2050 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2005 | 5179 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 13033 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 2007 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1990 | 110 | 0.020 |
Why?
|
| Cells, Cultured | 5 | 2009 | 19229 | 0.020 |
Why?
|
| Electrolytes | 1 | 1990 | 282 | 0.020 |
Why?
|
| Thymine | 1 | 2009 | 68 | 0.020 |
Why?
|
| Periodontal Attachment Loss | 1 | 2009 | 141 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 1995 | 743 | 0.020 |
Why?
|
| Periodontal Pocket | 1 | 2009 | 166 | 0.020 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2009 | 44 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 2959 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 1999 | 5097 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1723 | 0.020 |
Why?
|
| Keratinocytes | 2 | 2005 | 798 | 0.020 |
Why?
|
| Jejunum | 1 | 1990 | 480 | 0.020 |
Why?
|
| Cytosine | 1 | 2009 | 216 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2009 | 21746 | 0.020 |
Why?
|
| Luteolin | 1 | 2007 | 12 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 7722 | 0.020 |
Why?
|
| Health Policy | 1 | 2020 | 2661 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3768 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2007 | 8436 | 0.020 |
Why?
|
| Lymphocyte Subsets | 2 | 2001 | 315 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 350 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4409 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 5867 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1999 | 4386 | 0.020 |
Why?
|
| Alveolar Bone Loss | 1 | 2009 | 383 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 690 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 411 | 0.020 |
Why?
|
| Mink | 1 | 2005 | 44 | 0.020 |
Why?
|
| Adult | 11 | 2009 | 214055 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2003 | 2373 | 0.020 |
Why?
|
| Diploidy | 1 | 2005 | 138 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2003 | 6171 | 0.020 |
Why?
|
| Animals | 10 | 2022 | 168757 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 2839 | 0.020 |
Why?
|
| DNA Primers | 2 | 2000 | 2892 | 0.020 |
Why?
|
| Histidine | 1 | 2005 | 313 | 0.020 |
Why?
|
| Cricetinae | 2 | 1998 | 2472 | 0.020 |
Why?
|
| Genome | 2 | 2003 | 1808 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 7301 | 0.010 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 2886 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 893 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9274 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| Immunoglobulin G | 3 | 2001 | 4560 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 595 | 0.010 |
Why?
|
| Alanine | 1 | 2005 | 572 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1801 | 0.010 |
Why?
|
| Mutation | 2 | 2005 | 29786 | 0.010 |
Why?
|
| Antibodies, Bacterial | 2 | 2001 | 1470 | 0.010 |
Why?
|
| DNA Replication | 2 | 2000 | 1399 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2001 | 3870 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2001 | 75 | 0.010 |
Why?
|
| Treponema | 1 | 2001 | 38 | 0.010 |
Why?
|
| Cell Division | 2 | 2000 | 4568 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2009 | 10481 | 0.010 |
Why?
|
| Collagenases | 1 | 2001 | 228 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 285 | 0.010 |
Why?
|
| Cell Cycle | 2 | 2000 | 2967 | 0.010 |
Why?
|
| Cathepsins | 1 | 2001 | 241 | 0.010 |
Why?
|
| Antibodies | 1 | 2009 | 2460 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2001 | 336 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1539 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 4740 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 190 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 2001 | 267 | 0.010 |
Why?
|
| Aged | 4 | 2007 | 163280 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 668 | 0.010 |
Why?
|
| Fusobacterium nucleatum | 1 | 2001 | 162 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 12072 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2000 | 428 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1999 | 363 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1526 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1981 | 271 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1970 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 563 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4328 | 0.010 |
Why?
|
| Forelimb | 1 | 1999 | 122 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 77 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 216 | 0.010 |
Why?
|
| Aging | 1 | 1997 | 8664 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1999 | 352 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 1102 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 199 | 0.010 |
Why?
|
| Lactones | 1 | 2000 | 329 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 319 | 0.010 |
Why?
|
| Amylases | 1 | 1998 | 173 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18370 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 273 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 281 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 411 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 444 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1999 | 576 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 876 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 2255 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1998 | 424 | 0.010 |
Why?
|
| Epithelium | 1 | 2001 | 1679 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 8428 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1998 | 462 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 761 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 2327 | 0.010 |
Why?
|
| Glycine | 1 | 1999 | 671 | 0.010 |
Why?
|
| Base Sequence | 2 | 2000 | 12797 | 0.010 |
Why?
|
| Mice | 5 | 2005 | 81183 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1997 | 317 | 0.010 |
Why?
|
| Organelles | 1 | 1998 | 264 | 0.010 |
Why?
|
| Neutrophils | 2 | 2001 | 3719 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3505 | 0.010 |
Why?
|
| Clone Cells | 1 | 1999 | 1692 | 0.010 |
Why?
|
| Sex Factors | 1 | 2009 | 10397 | 0.010 |
Why?
|
| Middle Aged | 7 | 2009 | 213383 | 0.010 |
Why?
|
| Campylobacter | 1 | 1995 | 59 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 1189 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1998 | 909 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2002 | 1783 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1994 | 17 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1997 | 575 | 0.010 |
Why?
|
| Rheumatoid Factor | 1 | 1995 | 188 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2645 | 0.010 |
Why?
|
| Vero Cells | 1 | 1995 | 485 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 3002 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 1904 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1950 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2752 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 21683 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 8987 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 3206 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4320 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 4217 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 675 | 0.010 |
Why?
|
| Risk Factors | 3 | 2009 | 72290 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 1434 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1999 | 2203 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 4217 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 6114 | 0.010 |
Why?
|
| Introns | 1 | 1994 | 991 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1990 | 57 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 40075 | 0.010 |
Why?
|
| Absorption | 1 | 1990 | 248 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1995 | 1880 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 15519 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 1537 | 0.010 |
Why?
|
| Family Health | 1 | 1995 | 1282 | 0.010 |
Why?
|
| Denervation | 1 | 1990 | 278 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4420 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3690 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3798 | 0.010 |
Why?
|
| Regeneration | 1 | 1997 | 1485 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16689 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 10252 | 0.010 |
Why?
|
| Alleles | 1 | 1999 | 6933 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1998 | 2924 | 0.000 |
Why?
|
| Chlorides | 1 | 1990 | 667 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11366 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 3508 | 0.000 |
Why?
|
| Cell Survival | 1 | 1998 | 5882 | 0.000 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2001 | 4479 | 0.000 |
Why?
|
| Software | 1 | 2001 | 4443 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12959 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1997 | 5974 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2001 | 57776 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2001 | 7729 | 0.000 |
Why?
|
| Biological Transport | 1 | 1990 | 2118 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 6386 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2274 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 3912 | 0.000 |
Why?
|
| Adolescent | 3 | 2001 | 85781 | 0.000 |
Why?
|
| Sodium | 1 | 1990 | 1623 | 0.000 |
Why?
|
| Models, Biological | 1 | 2001 | 9583 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 6489 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2007 | 23403 | 0.000 |
Why?
|
| Rats | 1 | 2000 | 24260 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1999 | 9146 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16365 | 0.000 |
Why?
|
| Lung | 1 | 2000 | 9856 | 0.000 |
Why?
|
| Child | 2 | 2001 | 77709 | 0.000 |
Why?
|
| Prognosis | 1 | 2001 | 29063 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 25043 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2001 | 40561 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 41006 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 29144 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 7474 | 0.000 |
Why?
|